https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

FDA Grants Accelerated Approval to Dordaviprone For Diffuse Midline Glioma

FDA Grants Accelerated Approval to Dordaviprone For Diffuse Midline Glioma

The FDA approves dordaviprone, the first systemic therapy for H3 K27M-mutant diffuse midline glioma, offering hope for patients with limited options.

administrator

Related Articles